WSO - January 2024 - 114

1191033
WSO
International Journal of StrokeCostalat et al.
Protocol
Evaluation of acute mechanical
revascularization in large stroke
(ASPECTS ⩽5) and large vessel
occlusion within 7 h of last-seen-well:
The LASTE multicenter, randomized,
clinical trial protocol
Vincent Costalat1, Bertrand Lapergue2, JF Albucher3, Julien
Labreuche4, Hilde Henon5, Benjamin Gory6 , Igor Sibon7,
Grégoire Boulouis8 , Christophe Cognard9, Nasreddine Nouri10,
Sebastien Richard11, Gauthier Marnat12 , Federico Di Maria13,
Mariam Annan14, Alain Duhamel4, Federico Cagnazzo1,
Tudor Jovin15 and Caroline Arquizan16
; for the LASTE Trial
Investigators
Abstract
Rationale: Mechanical thrombectomy (MT), the standard of care for acute ischemic stroke (AIS) secondary to large
vessel occlusion (LVO), is generally not offered to patients with large baseline infarct (core). Recent studies demonstrated
MT benefit in patients with anterior circulation stroke and large core (i.e. Alberta Stroke Program Early Computed
Tomography Score, ASPECTS 3-5). However, its benefit in patients with the largest core (ASPECTS 0-2) remains
unproven.
Aim: To compare the efficacy and safety of MT plus best medical treatment (BMT) and of BMT alone in patients with
ASPECTS 0-5 (baseline computed tomography (CT) or magnetic resonance imaging (MRI)) and anterior circulation LVO
within 7 h of last-seen-well.
Sample size estimate: To detect with a two-sided test at 5% significance level (80% power) a common odds ratio of
1.65 for 1-point reduction in the 90-day modified Rankin Scale (mRS) score in the MT + BMT arm versus BMT arm and
to anticipate 10% of patients with missing primary endpoint, 450 patients are planned to be included by 36 centers in
France, Spain, and the United States.
1Department of Neuroradiology, Hôpital Gui de Chauliac, Montpellier, France
2Department of Neurology, Hôpital Foch, Suresnes, France
3Department of Neurology, Hôpital Pierre-Paul Riquet, Toulouse, France
4Department of Biostatistics, Lille University Hospital, Lille, France
5Department of Neurology, Hôpital Salengro, Lille, France
6Department of Neuroradiology, Hôpital Central, Nancy, France
7Department of Neurology, Hôpital Pellegrin, Bordeaux, France
8Department of Neuroradiology, Hôpital Bretonneau, Tours, France
9Department of Neuroradiology, Hôpital Pierre-Paul Riquet, Toulouse, France
10Department of Neuroradiology, Hôpital Salengro, Lille, France
11Department of Neurology, Hôpital Central, Nancy, France
12Department of Neuroradiology, Hôpital Pellegrin, Bordeaux, France
13Department of Neuroradiology, Hôpital Foch, Suresnes, France
14Department of Neurology, Hôpital Bretonneau, Tours, France
15Cooper Neurological Institute, Camden, NJ, USA
16Department of Neurology, Hôpital Gui de Chauliac, Montpellier, France
Corresponding author:
Caroline Arquizan, Department of Neurology, Hôpital Gui de Chauliac, 80 Avenue Augustin Fliche, 34295 Montpellier, Cedex 5, France.
Email: c-arquizan@chu-montpellier.fr
International Journal of Stroke, 19(1)
International Journal of Stroke
2024, Vol. 19(1) 114 -119
© 2023 World Stroke Organization
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/17474930231191033
journals.sagepub.com/home/wso
https://doi.org/10.1177/17474930231191033
http://www.sagepub.com/journals-permissions https://www.doi.org/10.1177/17474930231191033 http://journals.sagepub.com/home/wso

WSO - January 2024

Table of Contents for the Digital Edition of WSO - January 2024

Content
WSO - January 2024 - Cover1
WSO - January 2024 - Cover2
WSO - January 2024 - 1
WSO - January 2024 - Content
WSO - January 2024 - 3
WSO - January 2024 - 4
WSO - January 2024 - 5
WSO - January 2024 - 6
WSO - January 2024 - 7
WSO - January 2024 - 8
WSO - January 2024 - 9
WSO - January 2024 - 10
WSO - January 2024 - 11
WSO - January 2024 - 12
WSO - January 2024 - 13
WSO - January 2024 - 14
WSO - January 2024 - 15
WSO - January 2024 - 16
WSO - January 2024 - 17
WSO - January 2024 - 18
WSO - January 2024 - 19
WSO - January 2024 - 20
WSO - January 2024 - 21
WSO - January 2024 - 22
WSO - January 2024 - 23
WSO - January 2024 - 24
WSO - January 2024 - 25
WSO - January 2024 - 26
WSO - January 2024 - 27
WSO - January 2024 - 28
WSO - January 2024 - 29
WSO - January 2024 - 30
WSO - January 2024 - 31
WSO - January 2024 - 32
WSO - January 2024 - 33
WSO - January 2024 - 34
WSO - January 2024 - 35
WSO - January 2024 - 36
WSO - January 2024 - 37
WSO - January 2024 - 38
WSO - January 2024 - 39
WSO - January 2024 - 40
WSO - January 2024 - 41
WSO - January 2024 - 42
WSO - January 2024 - 43
WSO - January 2024 - 44
WSO - January 2024 - 45
WSO - January 2024 - 46
WSO - January 2024 - 47
WSO - January 2024 - 48
WSO - January 2024 - 49
WSO - January 2024 - 50
WSO - January 2024 - 51
WSO - January 2024 - 52
WSO - January 2024 - 53
WSO - January 2024 - 54
WSO - January 2024 - 55
WSO - January 2024 - 56
WSO - January 2024 - 57
WSO - January 2024 - 58
WSO - January 2024 - 59
WSO - January 2024 - 60
WSO - January 2024 - 61
WSO - January 2024 - 62
WSO - January 2024 - 63
WSO - January 2024 - 64
WSO - January 2024 - 65
WSO - January 2024 - 66
WSO - January 2024 - 67
WSO - January 2024 - 68
WSO - January 2024 - 69
WSO - January 2024 - 70
WSO - January 2024 - 71
WSO - January 2024 - 72
WSO - January 2024 - 73
WSO - January 2024 - 74
WSO - January 2024 - 75
WSO - January 2024 - 76
WSO - January 2024 - 77
WSO - January 2024 - 78
WSO - January 2024 - 79
WSO - January 2024 - 80
WSO - January 2024 - 81
WSO - January 2024 - 82
WSO - January 2024 - 83
WSO - January 2024 - 84
WSO - January 2024 - 85
WSO - January 2024 - 86
WSO - January 2024 - 87
WSO - January 2024 - 88
WSO - January 2024 - 89
WSO - January 2024 - 90
WSO - January 2024 - 91
WSO - January 2024 - 92
WSO - January 2024 - 93
WSO - January 2024 - 94
WSO - January 2024 - 95
WSO - January 2024 - 96
WSO - January 2024 - 97
WSO - January 2024 - 98
WSO - January 2024 - 99
WSO - January 2024 - 100
WSO - January 2024 - 101
WSO - January 2024 - 102
WSO - January 2024 - 103
WSO - January 2024 - 104
WSO - January 2024 - 105
WSO - January 2024 - 106
WSO - January 2024 - 107
WSO - January 2024 - 108
WSO - January 2024 - 109
WSO - January 2024 - 110
WSO - January 2024 - 111
WSO - January 2024 - 112
WSO - January 2024 - 113
WSO - January 2024 - 114
WSO - January 2024 - 115
WSO - January 2024 - 116
WSO - January 2024 - 117
WSO - January 2024 - 118
WSO - January 2024 - 119
WSO - January 2024 - 120
WSO - January 2024 - 121
WSO - January 2024 - 122
WSO - January 2024 - 123
WSO - January 2024 - 124
WSO - January 2024 - 125
WSO - January 2024 - 126
WSO - January 2024 - Cover3
WSO - January 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com